| 000 | 01330 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518045557.0 | ||
| 264 | 0 | _c20200203 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a2363-8915 | ||
| 024 | 7 |
_a10.1515/dmpt-2018-0020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShaik, Munthaj | |
| 245 | 0 | 0 |
_aEnhanced oral bioavailability of linagliptin by the influence of gallic acid and ellagic acid in male Wistar albino rats: involvement of p-glycoprotein inhibition. _h[electronic resource] |
| 260 |
_bDrug metabolism and personalized therapy _c06 2019 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 |
_aEllagic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aGallic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aIntestines _xdrug effects |
| 650 | 0 | 4 |
_aLinagliptin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aVanapatla, Swaroopa Rani | |
| 773 | 0 |
_tDrug metabolism and personalized therapy _gvol. 34 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/dmpt-2018-0020 _zAvailable from publisher's website |
| 999 |
_c29852533 _d29852533 |
||